Clinical Trials

GenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

88 enrolled

Kidney Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Phase 4 Not yet recruiting

80 enrolled

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT07412405 2026-02-17

ACITAC-001

12 enrolled

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07383233 2026-02-03

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

18 enrolled

Lymphoma

NCT07352267 2026-01-20

Diagnostic Value and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy Versus Transbronchial Needle Aspiration in the Diagnosis of Lymphoma: a Randomized Controlled Trial

470 enrolled

Lymphoma

NCT05544968 2026-01-12

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

42 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT07335094 2026-01-12

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

60 enrolled

Lymphoma

NCT07289087 2025-12-17

QOL-ONE PRO-CT

LymphoidOther hematologic neoplasmPlasma cell

162 enrolled

Leukemia, Lymphoma, Multiple Myeloma

NCT07285174 2025-12-16

Shanghai Lymphoma Clinical Cohort

1,000 enrolled

Lymphoma

NCT07286539 2025-12-16

PEPOH

BreastGastrointestinalLymphoidOther hematologic neoplasmThoracic

150 enrolled

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Lymphoma, Motor Activity, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT07259941 2025-12-02

PET-CT in Lymphoma Among the Eldery

63 enrolled

Phase 2 Not yet recruiting

Lymphoma

NCT07244380 2025-11-24

Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.

38 enrolled

Phase 2 Not yet recruiting

Lymphoma

NCT07206264 2025-10-03

ADAPT-MCL

45 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT07198958 2025-09-30

MITOX

BreastGastrointestinalLymphoidPlasma cell

500 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT07196111 2025-09-29

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Phase EARLY_PHASE1 Not yet recruiting

12 enrolled

Burkitt Lymphoma, Lymphoma

NCT07192471 2025-09-25

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Phase 1/2 Not yet recruiting

72 enrolled

DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

116 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07131449 2025-08-20

succinylation

200 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia, Lymphoma

NCT07048353 2025-07-02

CAR-T，MTD

15 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Lymphoma, B-Cell

NCT07020260 2025-06-13

PACMAN

18 enrolled

Burkitt Lymphoma, Leukemia, Lymphoma

NCT05969821 2025-06-12

CHIS

LymphoidMyeloidOther hematologic neoplasm

1,000 enrolled

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT07013435 2025-06-10

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

254 enrolled

Lymphoma

NCT07014293 2025-06-10

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

254 enrolled

Lymphoma

NCT07008872 2025-06-06

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

40 enrolled

Lymphoma

NCT06788600 2025-04-02

WGc-043

15 enrolled